{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:52:30Z","timestamp":1791247950293,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"DOI":"10.1038\/s41585-026-01196-x","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:02:25Z","timestamp":1791219745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolution or revolution \u2014 the GALEAS Bladder molecular urine test for triaging patients with haematuria"],"prefix":"10.1038","author":[{"given":"Douglas G.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Silcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne Louise","family":"Douglas-Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2853-4293","authenticated-orcid":false,"given":"Richard T.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"1196_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1464-410X.1994.tb07482.x","volume":"73","author":"TH Lynch","year":"1994","unstructured":"Lynch, T. H., Waymont, B., Dunn, J. A., Hughes, M. A. & Wallace, D. M. Rapid diagnostic service for patients with haematuria. Br. J. Urol. 73, 147\u2013151 (1994).","journal-title":"Br. J. Urol."},{"key":"1196_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2023.08.002","author":"W Devlies","year":"2024","unstructured":"Devlies, W. et al. The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: a systematic review from the European Association of Urology Guidelines Office. Eur. Urol. Focus https:\/\/doi.org\/10.1016\/j.euf.2023.08.002 (2024).","journal-title":"Eur. Urol. Focus"},{"key":"1196_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.euo.2019.09.008","volume":"3","author":"B Russell","year":"2020","unstructured":"Russell, B. et al. A systematic review and meta-analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients. Eur. Urol. Oncol. 3, 239\u2013249 https:\/\/doi.org\/10.1016\/j.euo.2019.09.008 (2020).","journal-title":"Eur. Urol. Oncol."},{"key":"1196_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2026.08.005","author":"L Silcock","year":"2026","unstructured":"Silcock, L. et al. Real-world multicentre evaluation of GALEAS Bladder for detecting bladder cancer in UK NHS haematuria clinics. Eur. Urol. Oncol. https:\/\/doi.org\/10.1016\/j.euo.2026.08.005 (2026).","journal-title":"Eur. Urol. Oncol."},{"key":"1196_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.euo.2022.03.005","volume":"6","author":"DG Ward","year":"2023","unstructured":"Ward, D. G. et al. Highly sensitive and specific detection of bladder cancer via targeted ultra-deep sequencing of urinary DNA. Eur. Urol. Oncol. 6, 67\u201375 https:\/\/doi.org\/10.1016\/j.euo.2022.03.005 (2023).","journal-title":"Eur. Urol. Oncol."},{"key":"1196_CR6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/bju.14808","volume":"124","author":"DG Ward","year":"2019","unstructured":"Ward, D. G. et al. Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification. BJU Int. 124, 532\u2013544 https:\/\/doi.org\/10.1111\/bju.14808 (2019).","journal-title":"BJU Int."},{"key":"1196_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2015.281","author":"FS Togneri","year":"2016","unstructured":"Togneri, F. S. et al. Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA. Eur. J. Hum. Genet. https:\/\/doi.org\/10.1038\/ejhg.2015.281 (2016).","journal-title":"Eur. J. Hum. Genet."},{"key":"1196_CR8","doi-asserted-by":"publisher","first-page":"e0149756","DOI":"10.1371\/journal.pone.0149756","volume":"11","author":"DG Ward","year":"2016","unstructured":"Ward, D. G. et al. Multiplex PCR and next generation sequencing for the non-invasive detection of bladder cancer. PLoS ONE 11, e0149756 https:\/\/doi.org\/10.1371\/journal.pone.0149756 (2016).","journal-title":"PLoS ONE"},{"key":"1196_CR9","doi-asserted-by":"publisher","first-page":"S1652","DOI":"10.1016\/j.annonc.2025.09.130","volume":"36","author":"ND James","year":"2025","unstructured":"James, N. D. et al. LBA111 Randomized comparison of upfront magnetic resonance imaging versus transurethral resection for staging new bladder cancers: final survival analysis from the BladderPath trial. Ann. Oncol. 36, S1652 https:\/\/doi.org\/10.1016\/j.annonc.2025.09.130 (2025).","journal-title":"Ann. Oncol."},{"key":"1196_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bju.16206","volume":"133","author":"S Anderson","year":"2024","unstructured":"Anderson, S. et al. Perspectives on technology: to use or to reuse, that is the endoscopic question\u2014asystematic review of single-use endoscopes. BJU Int. 133, 14\u201324 https:\/\/doi.org\/10.1111\/bju.16206 (2024).","journal-title":"BJU Int."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01196-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01196-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01196-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:04:29Z","timestamp":1791245069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01196-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":10,"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1038\/s41585-026-01196-x","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"5 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.G.W. and R.T.B. co-developed the GALEAS Bladder urine test with Nonacus. R.T.B. is a paid consultant for Cystotech ApS (Denmark) and an unpaid charity trustee for Action Bladder Cancer UK (UK). L.S. is an employee of Nonacus. Study funding from Nonacus Limited, UK. J.L.D.-M. declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}